Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Subscribe To Our Newsletter & Stay Updated
